Former President and Chief Executive Officer and Director · MYRIAD GENETICS INC (MYGN)

Mark Capone

A named executive officer of MYRIAD GENETICS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$6,174,458

Salary $870,560Stock awards $4,489,500

FY2019: $8,896,684

2nd of 8 named executive officers at Myriad Genetics by FY2020 total.

8 named officers on file for MYRIAD GENETICS, FY2020

Mark Capone’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • MYGN’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MYRIAD GENETICS’s whole pay program stands against its peers

  • MYRIAD GENETICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MYGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 15, 2020 (DEF 14A).

Free

Get Mark Capone’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Capone compensation by year

MYRIAD GENETICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as MYRIAD GENETICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$800,000$852,000$852,000$887,000$870,560
Bonus$512$307$0$200$0
Stock awards$3,361,875$3,613,500$5,374,050$7,177,500$4,489,500
Option awards$0$0$0$0$0
Non-equity incentive$727,200$741,240$817,920$802,735$184,211
Pension and deferred compensation$0$0$0$0$0
All other$11,048$10,848$10,980$29,249$630,187
Total$4,900,635$5,217,895$7,054,950$8,896,684$6,174,458

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MYRIAD GENETICS INC DEF 14A filed October 15, 2020, accession 0001193125-20-269774, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MYRIAD GENETICS INC filed document, accession 0001193125-20-269774. Every figure is read from that document and cited to the page and table it appears in. Filed October 15, 2020.

$4.9M
$5.2M
$7.1M
$8.9M
$6.2M
FY16
FY17
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
PSU150,000$4,167,000—
RSU123,750$3,437,775—
RSU82,500$2,291,850—
RSU19,676$546,599—

Per the Outstanding Equity Awards at Fiscal Year-End table in MYRIAD GENETICS INC's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

MYRIAD GENETICS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Paul DiazPresident and Chief Executive Officer$15,500,821
Mark Capone · this pageFormer President and Chief Executive Officer and Director$6,174,458
R. Bryan RiggsbeeChief Financial Officer and Treasurer; Interim President and Chief Executive Officer$4,203,341
Alexander FordFormer Chief Operating Officer$2,183,043
Gary KingFormer Executive Vice President International Operations$1,961,159
Bernard TobinFormer President of Myriad Autoimmune$1,879,045
Jerry LanchburyChief Scientific Officer$1,829,238
Nicole LambertWomen’s Health, Oncology, and International$1,704,706

The full MYRIAD GENETICS compensation record

free company brief

This page is one person within MYRIAD GENETICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MYRIAD GENETICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MYRIAD GENETICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Capone's compensation dossier · One-time report. No refunds.